Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Recruiting 6Terminated 3Active not recruiting 2Unknown 1No longer available 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 1Glioblastoma 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 184Nivolumab 180Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 111Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74Radiation 73atezolizumab 72venetoclax 68fludarabine 68Gemcitabine 68Standard of Care 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × fluorodopa F 18 × Clear all
NCT02104310 2026-04-06

A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas

Mayo Clinic

Active not recruiting
25 enrolled
CNS

Glioma

NCT05781321 2026-02-03

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

Mayo Clinic

Phase 2 Active not recruiting
170 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡